Dallah Healthcare Company SJSC
SAU:4004
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
154.2
188
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dallah Healthcare Company SJSC
Dallah Healthcare Company SJSC
Accounts Receivables
Dallah Healthcare Company SJSC
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dallah Healthcare Company SJSC
SAU:4004
|
Accounts Receivables
ď·Ľ819.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
20%
|
CAGR 10-Years
13%
|
|
|
National Medical Care Company JSC
SAU:4005
|
Accounts Receivables
ď·Ľ619m
|
CAGR 3-Years
61%
|
CAGR 5-Years
27%
|
CAGR 10-Years
8%
|
|
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
Accounts Receivables
ď·Ľ1.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
|
|
A
|
Al Hammadi Holding Co
SAU:4007
|
Accounts Receivables
ď·Ľ437m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
15%
|
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
Accounts Receivables
ď·Ľ703.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
Accounts Receivables
ď·Ľ848m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dallah Healthcare Company SJSC
Glance View
Dallah Healthcare Co. engages in the provision and operation of healthcare programs and utilities. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2012-12-16. The firm operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitals’ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicines’ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Office’s segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.
See Also
What is Dallah Healthcare Company SJSC's Accounts Receivables?
Accounts Receivables
819.6m
SAR
Based on the financial report for Jun 30, 2024, Dallah Healthcare Company SJSC's Accounts Receivables amounts to 819.6m SAR.
What is Dallah Healthcare Company SJSC's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
13%
Over the last year, the Accounts Receivables growth was 5%. The average annual Accounts Receivables growth rates for Dallah Healthcare Company SJSC have been 12% over the past three years , 20% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
